Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2018 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer.
Pharmaceuticals (Basel). 2021 May 29;14(6):523. doi: 10.3390/ph14060523.
Pharmaceuticals (Basel). 2021.
PMID: 34072442
Free PMC article.
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.
Doldi V, Lecchi M, Ljevar S, Colecchia M, Campi E, Centonze G, Marenghi C, Rancati T, Miceli R, Verderio P, Valdagni R, Gandellini P, Zaffaroni N.
Doldi V, et al. Among authors: campi e.
Int J Mol Sci. 2022 Jul 20;23(14):7987. doi: 10.3390/ijms23147987.
Int J Mol Sci. 2022.
PMID: 35887333
Free PMC article.
Item in Clipboard
Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.
Bedini N, Cicchetti A, Palorini F, Magnani T, Zuco V, Pennati M, Campi E, Allavena P, Pesce S, Villa S, Avuzzi B, Morlino S, Visentin ME, Zaffaroni N, Rancati T, Valdagni R.
Bedini N, et al. Among authors: campi e.
Dis Markers. 2018 Feb 25;2018:9128128. doi: 10.1155/2018/9128128. eCollection 2018.
Dis Markers. 2018.
PMID: 29682101
Free PMC article.
Clinical Trial.
Item in Clipboard
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables.
Gandellini P, Ciniselli CM, Rancati T, Marenghi C, Doldi V, El Bezawy R, Lecchi M, Claps M, Catanzaro M, Avuzzi B, Campi E, Colecchia M, Badenchini F, Verderio P, Valdagni R, Zaffaroni N.
Gandellini P, et al. Among authors: campi e.
Cancers (Basel). 2021 May 18;13(10):2433. doi: 10.3390/cancers13102433.
Cancers (Basel). 2021.
PMID: 34069838
Free PMC article.
Item in Clipboard
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
Pennati M, Sbarra S, De Cesare M, Lopergolo A, Locatelli SL, Campi E, Daidone MG, Carlo-Stella C, Gianni AM, Zaffaroni N.
Pennati M, et al. Among authors: campi e.
Int J Cancer. 2015 Jan 15;136(2):299-309. doi: 10.1002/ijc.28993. Epub 2014 Jun 5.
Int J Cancer. 2015.
PMID: 24866585
Free article.
Item in Clipboard
Cite
Cite